Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open pilot study of buprenorphine transdermal system add-on treatment for chronic neuropathic pain
2006-001204-36Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Mar 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of buprenorphine in chronic neuropathic pain, sponsored by Carlo Besta Neurological Institute. Primary endpoint: Pain control. Started Mar 2006; status: completed.
02
Drugs
buprenorphine
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on 2006-001204-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001204-36.